Delivery Order SPE2DE24D0021-SPE2D625F3RAH
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,080 fixed-price delivery order with economic price adjustment to Fisher Scientific Company L.L.C. for antigen COVID-19 testing kits on September 10, 2025. The contract, which serves as a child order under a larger vehicle, is scheduled for completion by September 17, 2025, with performance taking place in Pittsburgh, Pennsylvania. This delivery order represents a continuation of the government's pandemic response efforts,...
- The U.S. Defense Department's Medical Supply Chain division awarded Fisher Scientific Company L.L.C. a delivery order valued at $3,080 for antigen COVID-19 testing kits on August 20, 2025, with an ultimate completion date of August 27, 2025. The contract is structured as fixed price with economic price adjustment and will be performed in Pittsburgh, Pennsylvania. This award was made through open competition with no set-aside designations, reflecting Fisher Scientific's established capability...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract for BinaxNow COVID-19 antigen testing kits on September 16, 2025, with a ceiling value of $1,960. The contract, issued by the Defense Medical Supply Chain, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting open competition in the award process. Performance will be executed in Pittsburgh, Pennsylvania, with an ultimate completion date of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on September 16, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits to support the Medical Supply Chain program within the Department of Defense. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 23, 2025. As a child contract under a larger vehicle, this delivery order represents Fisher Scientific's role as a critical...
- The U.S. Department of Defense has awarded a $5,184 fixed-price delivery order contract to Fisher Scientific Company L.L.C. for the provision of 4,565,083,211 BinaxNOW COVID-19 antigen test kits. This order was placed under the Medical Supply Chain contract with the Defense agency. The contract has an ultimate completion date of July 15, 2024 and does not utilize any set-aside designations. Fisher Scientific, a large for-profit limited liability company, has a strong track record of supporting...
- The U.S. Medical Supply Chain, a Defense Department component, awarded a $1,546.93 fixed-price delivery order with economic price adjustment to Fisher Scientific Company L.L.C. on May 6, 2025, for BinaxNOW COVID-19 antigen testing kits. The contract is set to be completed by June 6, 2025, with performance taking place in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger vehicle and was awarded through open competition with no set-aside designation,...
- This is a firm-fixed-price delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency, to Fisher Scientific Company L.L.C. for the provision of COVID-19 test kits and related supplies. The total ceiling value of the contract is $2,191.00, with an initial task order of $365,822.55 for the delivery of microbiology consumables to the Pittsburgh, PA facility. The contract has an ultimate completion date of December 14, 2023 and does not have a...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 4, 2025, for BinaxNow COVID-19 antigen over-the-counter rapid test kits (12 tests per 2-count case) valued at $1,311.20. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain division within the Department of Defense and is set to be completed by August 11, 2025. The contract represents a child award under a larger vehicle and specifies performance in Pittsburgh,...
- This federal contract award, valued at $2,695.00, was issued by the Medical Supply Chain, a component of the Department of Defense, to Fisher Scientific Company L.L.C. (doing business as Fisher Scientific) on September 16, 2024. The award is for the delivery of COVID-19 antigen testing kits through a fixed-price delivery order contract without a set-aside designation. The contract has an ultimate completion date of September 23, 2024. Fisher Scientific is a major supplier of scientific products,...
- Fisher Scientific Company L.L.C. received a delivery order award on August 22, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract carries a ceiling value of $2,213.20 and is structured as a fixed-price agreement with economic price adjustment provisions. Funding originates from the Medical Supply Chain division within the Department of Defense. The place of performance is listed as Pittsburgh, PA. This delivery order represents a child contract, indicating it falls...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3RAHDelivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order contract to Fisher Scientific Company L.L.C. for coronavirus test kits on September 17, 2025, with a ceiling value of $3,060.36 and an ultimate completion date of September 24, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, indicating the award resulted from open competition. The contract will be performed in Pittsburgh, Pennsylvania, and represents a child contract under a larger acquisition vehicle. Fisher Scientific, a major supplier of scientific products and medical equipment to federal agencies since its SAM.gov registration in 2001, was selected based on its established capabilities in providing specialized testing solutions and medical supplies across multiple government departments. This award supports the Defense Department's medical supply chain operations through the procurement of coronavirus diagnostic test kits, likely supporting military health readiness and personnel testing requirements. The relatively modest ceiling value reflects the specific scope of this delivery order rather than a comprehensive procurement vehicle. Fisher Scientific's selection underscores the company's competitive position in the federal marketplace, having successfully delivered advanced laboratory and medical equipment to numerous agencies including the National Institutes of Health, Department of Veterans Affairs, and various defense-related entities. The short completion timeline of one week suggests this represents an urgent or routine replenishment order within an existing contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/17/25 |